Meta-analysis of the effect of sevelamer on phosphorus, calcium, PTH, and serum lipids in dialysis patients
- 30 April 2003
- journal article
- research article
- Published by Elsevier in Advances in Renal Replacement Therapy
- Vol. 10 (2) , 133-145
- https://doi.org/10.1053/jarr.2003.50016
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Secondary hyperparathyroidism in chronic renal failure: Pathogenic and clinical aspectsAmerican Journal of Kidney Diseases, 2001
- Association of Elevated Serum PO4, Ca × PO4 Product, and Parathyroid Hormone with Cardiac Mortality Risk in Chronic Hemodialysis PatientsJournal of the American Society of Nephrology, 2001
- Coronary-Artery Calcification in Young Adults with End-Stage Renal Disease Who Are Undergoing DialysisNew England Journal of Medicine, 2000
- Clinical epidemiology of cardiovascular disease in chronic renal diseaseAmerican Journal of Kidney Diseases, 1998
- Hyperlipidemia in patients with chronic renal diseaseAmerican Journal of Kidney Diseases, 1998
- Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: A national studyAmerican Journal of Kidney Diseases, 1998
- RnaGel(R), a novel calcium- and aluminium-free phosphate binder, inhibits phosphate absorption in normal volunteersNephrology Dialysis Transplantation, 1997
- Are we mismanaging calcium and phosphate metabolism in renal failure?American Journal of Kidney Diseases, 1997
- Phosphorus restriction prevents parathyroid gland growth. High phosphorus directly stimulates PTH secretion in vitro.Journal of Clinical Investigation, 1996
- Death Risk in Hemodialysis Patients: The Predictive Value of Commonly Measured Variables and an Evaluation of Death Rate Differences Between FacilitiesAmerican Journal of Kidney Diseases, 1990